Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: IL-23 inhibitors ×

IL-23 inhibitors

This drug is selected. Its supporting articles are shown below.

IL-23 inhibitors2

Articles mentioning IL-23 inhibitors

2 articles · page 1 of 1

Liver disease risk in patients with psoriasis treated with biologics

bmjimm · abstract · 2026-06-05 · 1 matching annotations

79.8%

IL-17i IL-23i TNFi tumour necrosis factor-alpha inhibitors IL-23 inhibitors IL-17 inhibitors liver disease psoriasis

…0.91) and fibrosis or cirrhosis (HR 0.81; 95% CI 0.70 to 0.92). IL-17i (4579 matched pairs) and TNFi (15 007 matched pairs) treatment …

4CPS-083 Clinical experience with the combination of risankizumab and other biologic agents in patient with refractory inflammatory bowel disease: efficacy, disease course and safety profile

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

78.8%

risankizumab vedolizumab infliximab adalimumab IL-23 inhibitors refractory inflammatory bowel disease Crohn’s disease ulcerative colitis inflammatory bowel disease perianal disease

…re recorded. At the end of follow-up, two patients continued on risankizumab monotherapy, while three maintained the combination therapy.Con…